US Patent

US10996208 — Abaloparatide formulations and methods of testing, storing, modifying, and using same

Formulation · Assigned to Radius Health Inc · Expires 2038-04-30 · 12y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects methods of analyzing, storing, and using abaloparatide, specifically in relation to its isomers.

USPTO Abstract

Provided herein are newly discovered methods of analyzing abaloparatide samples for abaloparatide isomers. Additionally, methods of storing and treating with abaloparatide in view of the newly discovered abaloparatide isomers are described.

Drugs covered by this patent

Patent Metadata

Patent number
US10996208
Jurisdiction
US
Classification
Formulation
Expires
2038-04-30
Drug substance claim
No
Drug product claim
Yes
Assignee
Radius Health Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.